Targeting GSTP1-dependent ferroptosis in lung cancer radiotherapy: Existing evidence and future directions

11Citations
Citations of this article
12Readers
Mendeley users who have this article in their library.

Abstract

Radiotherapy is applied in about 70% patients with tumors, yet radioresistance of tumor cells remains a challenge that limits the efficacy of radiotherapy. Ferroptosis, an iron-dependent lipid peroxidation regulated cell death, is involved in the development of a variety of tumors. Interestingly, there is evidence that ferroptosis inducers in tumor treatment can significantly improve radiotherapy sensitivity. In addition, related studies show that Glutathione S-transferase P1 (GSTP1) is closely related to the development of ferroptosis. The potential mechanism of targeting GSTP1 to inhibit tumor cells from evading ferroptosis leading to radioresistance has been proposed in this review, which implies that GSTP1 may play a key role in radiosensitization of lung cancer via ferroptosis pathway.

Cite

CITATION STYLE

APA

Tan, X., Huang, X., Niu, B., Guo, X., Lei, X., & Qu, B. (2022, December 16). Targeting GSTP1-dependent ferroptosis in lung cancer radiotherapy: Existing evidence and future directions. Frontiers in Molecular Biosciences. Frontiers Media S.A. https://doi.org/10.3389/fmolb.2022.1102158

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free